Modulation of cartilage differentiation by melanoma inhibiting activity/cartilage-derived retinoic acid-sensitive protein (MIA/CD-RAP)

Experimental and Molecular Medicine

Volumn 42, Issue 3, 2010, Pages 166-174

  Schubert, Thomas ^a   Schlegel, Jacqueline ^a   Schmid, Rainer ^a   Opolka, Alfred ^a   Grässel, Susanne ^a   Humphries, Martin ^b   Bosserhoff, Anja Katrin ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Bone morphogenetic protein 2; Cartilage; Cell differentiation; Chondrocytes; Human; MIA protein

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; AGGRECAN; BONE MORPHOGENETIC PROTEIN 2; CHORDIN; MELANOMA INHIBITING ACTIVITY PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; OSTEOCALCIN; SMAD PROTEIN; TUMOR PROTEIN; UNCLASSIFIED DRUG; ALPHA5 INTEGRIN; BONE MORPHOGENETIC PROTEIN; MIA PROTEIN, HUMAN; MIA1 PROTEIN, MOUSE; PROTEIN BINDING; SCLEROPROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARTILAGE CELL; CELL DIFFERENTIATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IN VIVO STUDY; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; ANIMAL; BONE DEVELOPMENT; CARTILAGE; CYTOLOGY; DEFICIENCY; ENZYMOLOGY; MESENCHYMAL STROMA CELL; METABOLISM;

MUS;

ANIMALS; BONE MORPHOGENETIC PROTEINS; CARTILAGE; CELL DIFFERENTIATION; CHONDROCYTES; EXTRACELLULAR MATRIX PROTEINS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; INTEGRIN ALPHA5; MESENCHYMAL STROMAL CELLS; MICE; NEOPLASM PROTEINS; OSTEOGENESIS; PROTEIN BINDING; SIGNAL TRANSDUCTION; SMAD PROTEINS;

EID: 77950546729     PISSN: 12263613     EISSN: 20926413     Source Type: Journal    
DOI: 10.3858/emm.2010.42.3.017     Document Type: Article

References (30)

1. Bauer R, Humphries M, Fassler R, Winklmeier A, Craig SE, Bosserhoff AK. Regulation of integrin activity by MIA. J Biol Chem 2006;281:11669-77
2. Blesch A, Bosserhoff AK, Apfel R, Behl C, Hessdoerfer B, Schmitt A, Jachimczak P, Lottspeich F, Buettner R, Bogdahn U. Cloning of a novel malignant melanoma-derived growth-regulatory protein, MIA. Cancer Res 1994;54:5695-701
3. Bobick BE, Kulyk WM. The MEK-ERK signaling pathway is a negative regulator of cartilage-specific gene expression in embryonic limb mesenchyme. J Biol Chem 2004;279: 4588-95
4. Bosserhoff AK, Buettner R. Establishing the protein MIA (melanoma inhibitory activity) as a marker for chondrocyte differentiation. Biomaterials 2003;24:3229-34
5. Bosserhoff AK, Kondo S, Moser M, Dietz UH, Copeland NG, Gilbert DJ, Jenkins NA, Buettner R, Sandell LJ. Mouse CD-RAP/MIA gene: structure, chromosomal localization, and expression in cartilage and chondrosarcoma. Dev Dyn 1997;208:516-25
6. Bosserhoff AK, Stoll R, Sleeman JP, Bataille F, Buettner R, Holak TA. Active detachment involves inhibition of cell-matrix contacts of malignant melanoma cells by secretion of melanoma inhibitory activity. Lab Invest 2003;83:1583-94
7. Bullough PG, Jagannath A. The morphology of the calcification front in articular cartilage. Its significance in joint function. J Bone Joint Surg Br 1983;65:72-8
8. Dietz UH, Sandell LJ. Cloning of a retinoic acid-sensitive mRNA expressed in cartilage and during chondrogenesis. J Biol Chem 1996;271:3311-6
9. Forsyth CB, Pulai J, Loeser RF. Fibronectin fragments and blocking antibodies to alpha2beta1 and alpha5beta1 integrins stimulate mitogen-activated protein kinase signa-ling and increase collagenase 3 (matrix metalloproteinase 13) production by human articular chondrocytes. Arthritis Rheum 2002;46:2368-76
10. Gannon JM, Walker G, Fischer M, Carpenter R, Thompson RC Jr, Oegema TR Jr. Localization of type X collagen in canine growth plate and adult canine articular cartilage. J Orthop Res 1991;9:485-94
11. Hoyland JA, Thomas JT, Donn R, Marriott A, Ayad S, Boot-Handford RP, Grant ME, Freemont AJ. Distribution of type X collagen mRNA in normal and osteoarthritic human cartilage. Bone Miner 1991;15:151-63
12. Hughes LC, Archer CW, ap I G. The ultrastructure of mouse articular cartilage: collagen orientation and implications for tissue functionality. A polarised light and scanning electron microscope study and review. Eur Cell Mater 2005;9:68-84
13. Kirsch T, von der Mark K. Isolation of human type X collagen and immunolocalization in fetal human cartilage. Eur J Biochem 1991;196:575-80
14. Lane LB, Villacin A, Bullough PG. The vascularity and remodelling of subchondrial bone and calcified cartilage in adult human femoral and humeral heads. An age- and stress-related phenomenon. J Bone Joint Surg Br 1977;59: 272-8
15. Lou J, Tu Y, Li S, Manske PR. Involvement of ERK in BMP-2 induced osteoblastic differentiation of mesenchymal progenitor cell line C3H10T1/2. Biochem Biophys Res Commun 2000;268:757-62
16. Lougheed JC, Holton JM, Alber T, Bazan JF, Handel TM. Structure of melanoma inhibitory activity protein, a member of a recently identified family of secreted proteins. Proc Natl Acad Sci USA 2001;98:5515-20
17. Moser M, Bosserhoff AK, Hunziker EB, Sandell L, Fassler R, Buettner R. Ultrastructural cartilage abnormalities in MIA/CD-RAP-deficient mice. Mol Cell Biol 2002;22:1438-45
18. Revell PA, Pirie C, Amir G, Rashad S, Walker F. Metabolic activity in the calcified zone of cartilage: observations on tetracycline labelled articular cartilage in human osteoar-thritic hips. Rheumatol Int 1990;10:143-7
19. Sriram D, Jones A, Alatli-Burt I, Darendeliler MA. Effects of mechanical stimuli on adaptive remodeling of condylar cartilage. J Dent Res 2009;88:466-70
20. Stoll R, Bosserhoff A. Extracellular SH3 domain containing proteins- features of a new protein family. Curr Protein Pept Sci 2008;9:221-6
21. Stoll R, Lodermeyer S, Bosserhoff AK. Detailed analysis of MIA protein by mutagenesis. Biol Chem 2006;387:1601-6
22. Stoll R, Renner C, Zweckstetter M, Bruggert M, Ambrosius D, Palme S, Engh RA, Golob M, Breibach I, Buettner R, Voelter W, Holak TA, Bosserhoff AK. The extracellular human melanoma inhibitory activity (MIA) protein adopts an SH3 domain-like fold. EMBO J 2001;20:340-9
23. Tomiya M, Fujikawa K, Ichimura S, Kikuchi T, Yoshihara Y, Nemoto K. Skeletal unloading induces a full-thickness patellar cartilage defect with increase of urinary collagen II CTx degradation marker in growing rats. Bone 2009;44: 295-305
24. Tscheudschilsuren G, Bosserhoff AK, Schlegel J, Vollmer D, Anton A, Alt V, Schnettler R, Brandt J, Proetzel G. Regulation of mesenchymal stem cell and chondrocyte differentiation by MIA. Exp Cell Res 2006;312:63-72
25. von der Mark K, Kirsch T, Nerlich A, Kuss A, Weseloh G, Gluckert K, Stoss H. Type X collagen synthesis in human osteoarthritic cartilage. Indication of chondrocyte hypertro-phy. Arthritis Rheum 1992;35:806-11
26. Walker GD, Fischer M, Gannon J, Thompson RC Jr, Oegema TR Jr. Expression of type-X collagen in osteoarthritis. J Orthop Res 1995;13:4-12
27. Wenke AK, Grassel S, Moser M, Bosserhoff AK. The cartilage-specific transcription factor Sox9 regulates AP-2epsilon expression in chondrocytes. FEBS J 2009;276: 2494-504
28. Xie WF, Zhang X, Sandell LJ. The 2.2-kb promoter of cartilage-derived retinoic acid-sensitive protein controls gene expression in cartilage and embryonic mammary buds of transgenic mice. Matrix Biol 2000;19:501-9
29. Yee KL, Weaver VM, Hammer DA. Integrin-mediated signalling through the MAP-kinase pathway. IET Syst Biol 2008;2:8-15
30. Yu PB, Hong CC, Sachidanandan C, Babitt JL, Deng DY, Hoyng SA, Lin HY, Bloch KD, Peterson RT. Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolism. Nat Chem Biol 2008;4:33-41